Articles tagged "Kidney"

2021 American Transplant Congress
The Impact of Covid-19 in Kidney Transplant Recipients: A Systematic Review and Meta-analysis
J. Kumar¹, J. Pyda², I. Reccia³, F. VIrdis⁴, P. Bachul¹, R. Barth¹, Y. Becker¹, J. Fung¹, P. Witkowski¹
¹University of Chicago, Chicago, IL, ²Beth Israel, Boston, MA, ³Imperial College, London, United Kingdom, ⁴Royal London, London, United Kingdom
*Purpose: To determine pooled prevalence of clinical outcomes among hospitalized kidney transplant recipients with COVID-19 through meta-analysis.*Methods: A systematic database search between Dec1, 2019- Dec1,…
2021 American Transplant Congress
VP2 MRNA Distinguishes the Direct Injury and Inflammation Effects of Polyoma Virus (BK) Infection from the Cognate TCMR Response That Follows Immunosuppressive Minimization
P. F. Halloran¹, K. Famulski¹, K. S. Madill-Thomsen¹, G. Böhmig², G. Gupta³, M. Myślak⁴, O. Viklicky⁵, &. the INTERCOMEX Study Group⁶
¹Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada, ²Medical University of Vienna, Vienna, Austria, ³Virginia Commonwealth University, Richmond, VA, ⁴Pomeranian Medical University, Szczecin, Poland, ⁵Institute for Clinical and Experimental Medicine, Prague, Czech Republic, ⁶., Edmonton, AB, Canada
*Purpose: BK virus nephropathy (BKN) and T cell-mediated rejection (TCMR) are difficult to distinguish by histology but often coexist due to the necessity for immunosuppression…
2021 American Transplant Congress
A New Triage-based Approach to Managing Transplant Referrals
H. L. Walther
Division of Kidney & Pancreas Transplantation, UCI Health, Orange, CA
*Purpose: To develop and implement a novel triage-based approach to the management of referrals for kidney transplant evaluation*Methods: The transplant nurse coordinator dedicated to referral…
2021 American Transplant Congress
Estimated GFR by Serum Myo-inositol, Valine, Creatinine, and Cystatin-c Outperforms Current CKD-epi Equations in Renal Transplant Recipients
J. W. Meeusen¹, F. Stammler², J. Lieske³, M. Grassi², M. Shah⁴, E. Schiffer²
¹Cardiovascular Laboratory Medicine, Mayo Clinic, Rochester, MA, ²Research and Development, Numares, Boston, MA, ³Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, ⁴Clinical Research, Numares, Boston, MA
*Purpose: Current estimated GFR (eGFR) equations using creatinine and/or cystatin C do no perform well in kidney transplant (KTx) recipients. Therefore, some large transplant programs…
2021 American Transplant Congress
An Investigation of Surgeon’s Effect on Deceased-Donor Kidney Offers and Transplant Outcomes
A. C. Randa, J. P. Roberts
Department of Surgery, UCSF, San Francisco, CA
*Purpose: We studied the transplant surgeons' effect on accepting or rejecting the deceased donor kidney offers and their subsequent effect on transplant outcomes.*Methods: There are…
2021 American Transplant Congress
The Impact of Living Donors Aged 70 and Older on Living Donor Kidney Transplantation
T. Hiramitsu, T. Tomosugi, K. Futamura, M. Okada, N. Goto, T. Ichimori, S. Narumi, Y. Watarai
Nagoya Daini Red Cross Hospital, Nagoya Aichi, Japan
*Purpose: Due to the discrepancy between the number of patients on the waiting list and oragn supply, living donor kidney transplantation is more required. The…
2021 American Transplant Congress
Use of Donor-Derived Cell-Free DNA in Children with Kidney Transplantation: A Pilot Study
E. Winnicki, J. Brennan, M. McEnhill, P. Brakeman, E. Ku
UCSF, San Francisco, CA
*Purpose: Use of a blood test to detect donor-derived cell-free DNA (dd-cfDNA) levels has been shown to predict rejection in adults with kidney transplants. If…
2021 American Transplant Congress
Body Mass Index >35 Does Not Impact Kidney Transplant Outcomes or Health Related Quality of Life Despite BMI Class or Recipient Race
D. A. Walczak¹, E. Collins², E. Benedetti¹
¹Organ Transplant, University of Il Hospital and Health Sciences System, Chicago, IL, ²College of Nursing, Dept of Bio-behavioral Health Science, University of Illinois at Chicago, Chicago, IL
*Purpose: Kidney transplant [KTx] in recipients with BMI > 35 remains controversial and has not often been studied in recipients with BMI >40. There is…
2021 American Transplant Congress
The Impact of 4-weeks of Supervised Exercise on Frailty and Lower Extremity (LE) Function in Patients with Advanced Chronic Kidney Disease (CKD)
E. Lorenz, L. Hickson, R. Weatherly, K. Thompson, M. Hogan, C. Kennedy
Mayo Clinic, Rochester, MN
*Purpose: Although frailty is a modifiable risk factor for morbidity and mortality among kidney transplant (KT) candidates, the optimal duration of effective prehabilitation interventions is…
2021 American Transplant Congress
Efficacy of MAU868, a Novel BKV Neutralizing Monoclonal Antibody (mAb), for the Treatment of Severe BK Virus Nephropathy (BKVN) After Kidney Transplant
S. C. Jordan¹, N. Ammerman², M. Toyoda³, K. Lim², J. R. Abend⁴, A. Patick⁵, M. R. Hodges⁵, A. Vo², S. J. Kovacs⁶
¹Comprehensive Transplant Center, Cedars Sinai Medical Ctr, West Hollywood, CA, ²Comprehensive Transplant Center, Cedars Sinai Medical Ctr, Los Angeles, CA, ³Cedars Sinai Medical Ctr, Los Angeles, CA, ⁴Novartis Institutes for BioMedical Research, Virology Research, Emeryville, CA, ⁵Amplyx Pharmaceuticals, San Diego, CA, ⁶Novartis Institutes for BioMedical Research, Translational Medicine, East Hanover, NJ
*Purpose: BKV reactivation leading to nephropathy and allograft loss in kidney transplant (KT) recipients remains a clinical significant concern. No specific or effective anti-BKV therapies…